

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glomerular filtration (GO:0003094) | 6.96649109 |
| 2 | renal filtration (GO:0097205) | 6.26646400 |
| 3 | O-glycan processing (GO:0016266) | 6.04606128 |
| 4 | digestive system process (GO:0022600) | 5.99122706 |
| 5 | biomineral tissue development (GO:0031214) | 5.89377817 |
| 6 | endothelial cell chemotaxis (GO:0035767) | 5.70048201 |
| 7 | one-carbon compound transport (GO:0019755) | 5.35982750 |
| 8 | secretion by tissue (GO:0032941) | 4.79652917 |
| 9 | regulation of bone mineralization (GO:0030500) | 4.75932716 |
| 10 | positive regulation of respiratory burst (GO:0060267) | 4.66031111 |
| 11 | tissue homeostasis (GO:0001894) | 4.62266104 |
| 12 | negative regulation of ossification (GO:0030279) | 4.54613072 |
| 13 | complement activation, classical pathway (GO:0006958) | 4.44726178 |
| 14 | regulation of biomineral tissue development (GO:0070167) | 4.44256286 |
| 15 | polyol transport (GO:0015791) | 4.42003559 |
| 16 | body fluid secretion (GO:0007589) | 4.15126137 |
| 17 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.04294333 |
| 18 | complement activation (GO:0006956) | 3.94014158 |
| 19 | peptide cross-linking (GO:0018149) | 3.93164384 |
| 20 | extracellular matrix assembly (GO:0085029) | 3.87472770 |
| 21 | protein O-linked glycosylation (GO:0006493) | 3.85353719 |
| 22 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.83097016 |
| 23 | keratan sulfate catabolic process (GO:0042340) | 3.79102668 |
| 24 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.75526014 |
| 25 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.74637977 |
| 26 | extracellular fibril organization (GO:0043206) | 3.57050182 |
| 27 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.44130952 |
| 28 | positive regulation of chemokine secretion (GO:0090197) | 3.37331684 |
| 29 | ossification (GO:0001503) | 3.26660678 |
| 30 | transepithelial transport (GO:0070633) | 3.25341716 |
| 31 | angiotensin maturation (GO:0002003) | 3.12517172 |
| 32 | fibril organization (GO:0097435) | 3.10752728 |
| 33 | protein activation cascade (GO:0072376) | 3.09672718 |
| 34 | complement activation, alternative pathway (GO:0006957) | 3.09273448 |
| 35 | toxin metabolic process (GO:0009404) | 3.07987940 |
| 36 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.06109139 |
| 37 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.05890395 |
| 38 | renal absorption (GO:0070293) | 3.05852371 |
| 39 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.04803845 |
| 40 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.03342292 |
| 41 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.00689987 |
| 42 | axon extension involved in axon guidance (GO:0048846) | 3.00689987 |
| 43 | metanephric mesenchyme development (GO:0072075) | 2.97291434 |
| 44 | endothelium development (GO:0003158) | 2.92159583 |
| 45 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.88949323 |
| 46 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.87925982 |
| 47 | cell proliferation involved in kidney development (GO:0072111) | 2.85410719 |
| 48 | cell proliferation involved in metanephros development (GO:0072203) | 2.84376177 |
| 49 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.82842486 |
| 50 | metanephric nephron tubule development (GO:0072234) | 2.78391272 |
| 51 | metanephric tubule development (GO:0072170) | 2.78391272 |
| 52 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.77757308 |
| 53 | negative regulation of heart growth (GO:0061117) | 2.77757308 |
| 54 | regulation of chemokine secretion (GO:0090196) | 2.76265606 |
| 55 | negative regulation of muscle hypertrophy (GO:0014741) | 2.72386489 |
| 56 | endocrine hormone secretion (GO:0060986) | 2.71231767 |
| 57 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.70298008 |
| 58 | cell differentiation involved in metanephros development (GO:0072202) | 2.68828224 |
| 59 | cellular response to fluid shear stress (GO:0071498) | 2.66846086 |
| 60 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.64823285 |
| 61 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.64823285 |
| 62 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64077768 |
| 63 | defense response to Gram-negative bacterium (GO:0050829) | 2.62615626 |
| 64 | negative regulation of interleukin-8 production (GO:0032717) | 2.61690518 |
| 65 | regulation of respiratory burst (GO:0060263) | 2.60772802 |
| 66 | metanephric nephron epithelium development (GO:0072243) | 2.60245315 |
| 67 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.54875349 |
| 68 | fibroblast migration (GO:0010761) | 2.54807669 |
| 69 | defense response to fungus (GO:0050832) | 2.53515520 |
| 70 | kidney mesenchyme development (GO:0072074) | 2.50944815 |
| 71 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.49610950 |
| 72 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.49610950 |
| 73 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.48208070 |
| 74 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.47865413 |
| 75 | hydrogen peroxide catabolic process (GO:0042744) | 2.46017240 |
| 76 | glomerular visceral epithelial cell development (GO:0072015) | 2.44620594 |
| 77 | angiogenesis involved in wound healing (GO:0060055) | 2.40353656 |
| 78 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.40195040 |
| 79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.37180136 |
| 80 | keratinocyte differentiation (GO:0030216) | 2.35933087 |
| 81 | metanephric epithelium development (GO:0072207) | 2.35688847 |
| 82 | anatomical structure homeostasis (GO:0060249) | 2.33455276 |
| 83 | response to vitamin A (GO:0033189) | 2.33290192 |
| 84 | negative regulation of leukocyte migration (GO:0002686) | 2.31942038 |
| 85 | positive regulation of odontogenesis (GO:0042482) | 2.31236776 |
| 86 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.31107266 |
| 87 | negative regulation of adherens junction organization (GO:1903392) | 2.31080666 |
| 88 | negative regulation of focal adhesion assembly (GO:0051895) | 2.31080666 |
| 89 | negative regulation of cell junction assembly (GO:1901889) | 2.31080666 |
| 90 | ethanol oxidation (GO:0006069) | 2.29264717 |
| 91 | nephron epithelium development (GO:0072009) | 2.28977512 |
| 92 | regulation of ossification (GO:0030278) | 2.27814218 |
| 93 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.27096858 |
| 94 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.26609946 |
| 95 | response to progesterone (GO:0032570) | 2.26056569 |
| 96 | negative regulation of complement activation (GO:0045916) | 2.25109165 |
| 97 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.24882480 |
| 98 | negative regulation of bone mineralization (GO:0030502) | 16.0094085 |
| 99 | retina homeostasis (GO:0001895) | 14.9422376 |
| 100 | negative regulation of biomineral tissue development (GO:0070168) | 14.3370017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.18622685 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.97407536 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48981053 |
| 4 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 2.41751353 |
| 5 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.32671544 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27499304 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26620890 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.06417267 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86771904 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75968816 |
| 11 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.74521502 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72903219 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70726134 |
| 14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.68404145 |
| 15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66167566 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65564829 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.62417963 |
| 18 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53953654 |
| 19 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.53704715 |
| 20 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.53704715 |
| 21 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.53704715 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51219137 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51034723 |
| 24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42806086 |
| 25 | CJUN_26792858_Chip-Seq_BT549_Human | 1.40261529 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38612783 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38480890 |
| 28 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.37992415 |
| 29 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37921036 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35766579 |
| 31 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.28820913 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27541781 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.26612213 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23927414 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23816389 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22543418 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21690862 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.19298701 |
| 39 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.17896921 |
| 40 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.17595282 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14807998 |
| 42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14513101 |
| 43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14327633 |
| 44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14124460 |
| 45 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14124460 |
| 46 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13697266 |
| 47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12502935 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11728099 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10975999 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09815845 |
| 51 | ERA_21632823_ChIP-Seq_H3396_Human | 1.09732137 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07960749 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.05041563 |
| 54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.04703318 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.01525250 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01457882 |
| 57 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.01205700 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.01205700 |
| 59 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00977187 |
| 60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.98538926 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98323094 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98173207 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97780913 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97328420 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.97110519 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97057166 |
| 67 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96467071 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96360486 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96078958 |
| 70 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.96064179 |
| 71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92650009 |
| 72 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92090116 |
| 73 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91895197 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90287272 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89815695 |
| 76 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89659288 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88950344 |
| 78 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88817097 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.88787833 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88217902 |
| 81 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.87798019 |
| 82 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87610103 |
| 83 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85646118 |
| 84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85266787 |
| 85 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.84541063 |
| 86 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84417184 |
| 87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84184253 |
| 88 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.82355066 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82273230 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81582751 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81160852 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81114378 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80553435 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.78756834 |
| 95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78647622 |
| 96 | TBL1_22424771_ChIP-Seq_293T_Human | 0.77368011 |
| 97 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77015834 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.75171816 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.74652417 |
| 100 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.72607349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005275_abnormal_skin_tensile | 6.77356319 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.71144286 |
| 3 | MP0003724_increased_susceptibility_to | 5.07819437 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.42711647 |
| 5 | MP0005670_abnormal_white_adipose | 3.59980657 |
| 6 | MP0002009_preneoplasia | 2.73174648 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.69272335 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.64082558 |
| 9 | MP0002796_impaired_skin_barrier | 2.41897959 |
| 10 | MP0003828_pulmonary_edema | 2.21001171 |
| 11 | MP0004043_abnormal_pH_regulation | 2.19585961 |
| 12 | MP0002933_joint_inflammation | 2.17142779 |
| 13 | MP0001851_eye_inflammation | 2.15042376 |
| 14 | MP0003436_decreased_susceptibility_to | 1.99352973 |
| 15 | MP0001533_abnormal_skeleton_physiology | 1.98297098 |
| 16 | MP0010368_abnormal_lymphatic_system | 1.94077447 |
| 17 | MP0003303_peritoneal_inflammation | 1.88678253 |
| 18 | MP0002108_abnormal_muscle_morphology | 1.81848478 |
| 19 | MP0000751_myopathy | 1.78353973 |
| 20 | MP0005666_abnormal_adipose_tissue | 1.73256009 |
| 21 | MP0001879_abnormal_lymphatic_vessel | 1.67129645 |
| 22 | MP0000467_abnormal_esophagus_morphology | 1.63113117 |
| 23 | MP0002006_tumorigenesis | 1.61803714 |
| 24 | MP0001958_emphysema | 1.61350723 |
| 25 | MP0002060_abnormal_skin_morphology | 1.58178502 |
| 26 | MP0005423_abnormal_somatic_nervous | 1.57667846 |
| 27 | MP0001542_abnormal_bone_strength | 1.55583785 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.50441144 |
| 29 | MP0006138_congestive_heart_failure | 1.48462906 |
| 30 | MP0005647_abnormal_sex_gland | 1.36846377 |
| 31 | MP0005023_abnormal_wound_healing | 1.35262983 |
| 32 | MP0005390_skeleton_phenotype | 1.34340871 |
| 33 | MP0003279_aneurysm | 1.33504840 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.31334440 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.26637752 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.26041564 |
| 37 | MP0000762_abnormal_tongue_morphology | 1.24128233 |
| 38 | MP0002249_abnormal_larynx_morphology | 1.20527813 |
| 39 | MP0009115_abnormal_fat_cell | 1.20317522 |
| 40 | MP0005164_abnormal_response_to | 1.17930981 |
| 41 | MP0004858_abnormal_nervous_system | 1.14258659 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.14199924 |
| 43 | MP0000767_abnormal_smooth_muscle | 1.11082633 |
| 44 | MP0001853_heart_inflammation | 1.10693843 |
| 45 | MP0002295_abnormal_pulmonary_circulatio | 1.10249067 |
| 46 | MP0001661_extended_life_span | 1.08218305 |
| 47 | MP0002971_abnormal_brown_adipose | 1.07564216 |
| 48 | MP0003075_altered_response_to | 1.07249152 |
| 49 | MP0000681_abnormal_thyroid_gland | 1.05677220 |
| 50 | MP0002127_abnormal_cardiovascular_syste | 1.04961970 |
| 51 | MP0004883_abnormal_blood_vessel | 1.04299626 |
| 52 | MP0000249_abnormal_blood_vessel | 1.04259236 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.00804617 |
| 54 | MP0005508_abnormal_skeleton_morphology | 0.99564711 |
| 55 | MP0004036_abnormal_muscle_relaxation | 0.97944715 |
| 56 | MP0005375_adipose_tissue_phenotype | 0.97389216 |
| 57 | MP0003638_abnormal_response/metabolism_ | 0.97192516 |
| 58 | MP0010386_abnormal_urinary_bladder | 0.95090279 |
| 59 | MP0004272_abnormal_basement_membrane | 0.90753948 |
| 60 | MP0002133_abnormal_respiratory_system | 0.89436613 |
| 61 | MP0005388_respiratory_system_phenotype | 0.89436613 |
| 62 | MP0004084_abnormal_cardiac_muscle | 0.89218879 |
| 63 | MP0003045_fibrosis | 0.87584586 |
| 64 | MP0010678_abnormal_skin_adnexa | 0.84780628 |
| 65 | MP0000685_abnormal_immune_system | 0.82698801 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 0.82497952 |
| 67 | MP0001545_abnormal_hematopoietic_system | 0.82497952 |
| 68 | MP0000470_abnormal_stomach_morphology | 0.81882752 |
| 69 | MP0005409_darkened_coat_color | 0.81479884 |
| 70 | MP0005248_abnormal_Harderian_gland | 0.77752743 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 0.77539523 |
| 72 | MP0000049_abnormal_middle_ear | 0.76880196 |
| 73 | MP0005330_cardiomyopathy | 0.76414202 |
| 74 | MP0000759_abnormal_skeletal_muscle | 0.76193694 |
| 75 | MP0005595_abnormal_vascular_smooth | 0.75851967 |
| 76 | MP0004087_abnormal_muscle_fiber | 0.75540273 |
| 77 | MP0009278_abnormal_bone_marrow | 0.75287393 |
| 78 | MP0005369_muscle_phenotype | 0.74478477 |
| 79 | MP0003690_abnormal_glial_cell | 0.72196189 |
| 80 | MP0008789_abnormal_olfactory_epithelium | 0.70799061 |
| 81 | MP0001243_abnormal_dermal_layer | 0.70150888 |
| 82 | MP0000343_altered_response_to | 0.69273367 |
| 83 | MP0001756_abnormal_urination | 0.68719691 |
| 84 | MP0005501_abnormal_skin_physiology | 0.68607685 |
| 85 | MP0008004_abnormal_stomach_pH | 0.65732790 |
| 86 | MP0004484_altered_response_of | 0.64674996 |
| 87 | MP0000613_abnormal_salivary_gland | 0.64537318 |
| 88 | MP0005387_immune_system_phenotype | 0.63414717 |
| 89 | MP0001790_abnormal_immune_system | 0.63414717 |
| 90 | MP0004130_abnormal_muscle_cell | 0.63340811 |
| 91 | MP0003091_abnormal_cell_migration | 0.63321844 |
| 92 | MP0002128_abnormal_blood_circulation | 0.60833184 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.59644077 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.59038843 |
| 95 | MP0003938_abnormal_ear_development | 0.58979398 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.58327470 |
| 97 | MP0001984_abnormal_olfaction | 0.57887584 |
| 98 | MP0005166_decreased_susceptibility_to | 0.57637196 |
| 99 | MP0000750_abnormal_muscle_regeneration | 0.54966950 |
| 100 | MP0010771_integument_phenotype | 0.54890430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 6.52434472 |
| 2 | Ulnar claw (HP:0001178) | 6.40219454 |
| 3 | Abnormality of complement system (HP:0005339) | 5.71025386 |
| 4 | Oral leukoplakia (HP:0002745) | 5.68901904 |
| 5 | Increased IgE level (HP:0003212) | 5.15223027 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.68100666 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 4.64882867 |
| 8 | Aortic aneurysm (HP:0004942) | 4.53187814 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.42516504 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 4.22532413 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 4.18895061 |
| 12 | Glomerulonephritis (HP:0000099) | 4.00221616 |
| 13 | Acanthosis nigricans (HP:0000956) | 3.88851342 |
| 14 | Nemaline bodies (HP:0003798) | 3.85859250 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 3.76305098 |
| 16 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.72539967 |
| 17 | Increased connective tissue (HP:0009025) | 3.70951690 |
| 18 | Protrusio acetabuli (HP:0003179) | 3.60739026 |
| 19 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.55398388 |
| 20 | Emphysema (HP:0002097) | 3.29482687 |
| 21 | Increased variability in muscle fiber diameter (HP:0003557) | 3.26879681 |
| 22 | Round ear (HP:0100830) | 3.25116824 |
| 23 | Obstructive sleep apnea (HP:0002870) | 3.23962212 |
| 24 | Nephritis (HP:0000123) | 3.12941928 |
| 25 | Pulmonary artery stenosis (HP:0004415) | 3.01369807 |
| 26 | Vascular tortuosity (HP:0004948) | 2.94663010 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.91405900 |
| 28 | Distal arthrogryposis (HP:0005684) | 2.81168733 |
| 29 | Insidious onset (HP:0003587) | 2.80504173 |
| 30 | Termporal pattern (HP:0011008) | 2.80504173 |
| 31 | Abnormal pupillary function (HP:0007686) | 2.80473087 |
| 32 | Upper limb muscle weakness (HP:0003484) | 2.79002301 |
| 33 | Peripheral hypomyelination (HP:0007182) | 2.78366377 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 2.64145203 |
| 35 | Foot dorsiflexor weakness (HP:0009027) | 2.62706290 |
| 36 | Lymphangioma (HP:0100764) | 2.58319211 |
| 37 | Action tremor (HP:0002345) | 2.54167377 |
| 38 | Increased CSF protein (HP:0002922) | 2.48204403 |
| 39 | Hypoplasia of the iris (HP:0007676) | 2.48110750 |
| 40 | Spinal rigidity (HP:0003306) | 2.47635027 |
| 41 | Exercise-induced myalgia (HP:0003738) | 2.43894900 |
| 42 | Abnormality of the foot musculature (HP:0001436) | 2.43734136 |
| 43 | Hematochezia (HP:0002573) | 2.42800322 |
| 44 | Mesangial abnormality (HP:0001966) | 2.41204157 |
| 45 | Hyperkalemia (HP:0002153) | 2.36927249 |
| 46 | Steppage gait (HP:0003376) | 2.33884867 |
| 47 | Oligomenorrhea (HP:0000876) | 2.29725732 |
| 48 | Aortic dissection (HP:0002647) | 2.28839365 |
| 49 | Hyperactive renin-angiotensin system (HP:0000841) | 2.27497778 |
| 50 | Hip contracture (HP:0003273) | 2.24975960 |
| 51 | Broad metatarsal (HP:0001783) | 2.21781563 |
| 52 | EMG: neuropathic changes (HP:0003445) | 2.21654304 |
| 53 | Sparse scalp hair (HP:0002209) | 2.19249472 |
| 54 | Areflexia of lower limbs (HP:0002522) | 2.18447057 |
| 55 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18197482 |
| 56 | Shallow orbits (HP:0000586) | 2.16791361 |
| 57 | Difficulty running (HP:0009046) | 2.14099628 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.13146394 |
| 59 | Abnormality of the ischium (HP:0003174) | 2.12469451 |
| 60 | Amyloidosis (HP:0011034) | 2.12139335 |
| 61 | Ulnar deviation of the wrist (HP:0003049) | 2.09661942 |
| 62 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.09468644 |
| 63 | Bone cyst (HP:0012062) | 2.07497448 |
| 64 | Neck muscle weakness (HP:0000467) | 2.07482311 |
| 65 | Dilatation of the ascending aorta (HP:0005111) | 2.07181386 |
| 66 | Vertebral compression fractures (HP:0002953) | 2.06575796 |
| 67 | Aneurysm (HP:0002617) | 2.05449288 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.05247303 |
| 69 | Erythroderma (HP:0001019) | 2.03124603 |
| 70 | Asymmetry of the thorax (HP:0001555) | 1.99077394 |
| 71 | Wormian bones (HP:0002645) | 1.97866376 |
| 72 | Keratoconjunctivitis (HP:0001096) | 1.93291023 |
| 73 | Cerebral aneurysm (HP:0004944) | 1.93121315 |
| 74 | Joint hemorrhage (HP:0005261) | 1.86896182 |
| 75 | Bronchomalacia (HP:0002780) | 1.86653736 |
| 76 | Villous atrophy (HP:0011473) | 1.85697535 |
| 77 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.85697535 |
| 78 | Slender build (HP:0001533) | 1.85677542 |
| 79 | Lip pit (HP:0100267) | 1.84035850 |
| 80 | Arterial tortuosity (HP:0005116) | 1.82349786 |
| 81 | Abnormality of the nasal mucosa (HP:0000433) | 1.79133109 |
| 82 | Calcaneovalgus deformity (HP:0001848) | 1.79068229 |
| 83 | Enlarged penis (HP:0000040) | 1.78633399 |
| 84 | Myopathic facies (HP:0002058) | 1.77337270 |
| 85 | Visceral angiomatosis (HP:0100761) | 1.76998072 |
| 86 | Growth hormone excess (HP:0000845) | 1.75423520 |
| 87 | Hypoplastic ischia (HP:0003175) | 1.72462131 |
| 88 | Hypercortisolism (HP:0001578) | 1.71109459 |
| 89 | Alopecia of scalp (HP:0002293) | 1.70544158 |
| 90 | Gingivitis (HP:0000230) | 1.69786793 |
| 91 | Tracheomalacia (HP:0002779) | 1.68266413 |
| 92 | EMG: myopathic abnormalities (HP:0003458) | 1.67718552 |
| 93 | Limited hip movement (HP:0008800) | 1.67442752 |
| 94 | Neoplasm of the heart (HP:0100544) | 1.66752283 |
| 95 | Rectal prolapse (HP:0002035) | 1.66750425 |
| 96 | Decreased motor nerve conduction velocity (HP:0003431) | 1.66063426 |
| 97 | Hemangiomatosis (HP:0007461) | 1.64373178 |
| 98 | Prolonged bleeding time (HP:0003010) | 1.63003570 |
| 99 | Bulbar palsy (HP:0001283) | 1.62207437 |
| 100 | Abnormality of the salivary glands (HP:0010286) | 1.62119591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPKAPK3 | 4.24315145 |
| 2 | OBSCN | 3.91769115 |
| 3 | ERN1 | 3.68917344 |
| 4 | MAP4K2 | 3.53988064 |
| 5 | MAPK15 | 2.70757598 |
| 6 | PIK3CA | 2.67452687 |
| 7 | RIPK1 | 2.46714257 |
| 8 | FRK | 2.43195224 |
| 9 | TRPM7 | 2.42253551 |
| 10 | DDR2 | 2.23052699 |
| 11 | EPHA2 | 2.19877673 |
| 12 | DMPK | 1.89600253 |
| 13 | BLK | 1.81016078 |
| 14 | TGFBR2 | 1.80718126 |
| 15 | TIE1 | 1.79356937 |
| 16 | EPHA3 | 1.76370529 |
| 17 | EPHB1 | 1.60463122 |
| 18 | WNK1 | 1.60092982 |
| 19 | MAPK7 | 1.59594958 |
| 20 | MST4 | 1.51436812 |
| 21 | STK3 | 1.51131661 |
| 22 | FER | 1.47167100 |
| 23 | MYLK | 1.45422209 |
| 24 | FGFR2 | 1.44136829 |
| 25 | TRIB3 | 1.42381559 |
| 26 | FGFR3 | 1.40287536 |
| 27 | RPS6KB2 | 1.31954123 |
| 28 | KIT | 1.28314505 |
| 29 | PIK3CG | 1.25679911 |
| 30 | ERBB3 | 1.23360901 |
| 31 | PDGFRA | 1.13270346 |
| 32 | MAP3K6 | 1.09782409 |
| 33 | LRRK2 | 1.09780288 |
| 34 | HIPK2 | 1.07489316 |
| 35 | NLK | 1.07030705 |
| 36 | EPHB2 | 1.06310440 |
| 37 | TTN | 1.02833233 |
| 38 | CSK | 1.00887806 |
| 39 | MAP2K2 | 0.98849075 |
| 40 | MAPKAPK2 | 0.96424359 |
| 41 | CDC42BPA | 0.96323202 |
| 42 | STK39 | 0.93386476 |
| 43 | MAPK12 | 0.91363299 |
| 44 | FES | 0.89267981 |
| 45 | TYK2 | 0.88937723 |
| 46 | MAPK4 | 0.85127127 |
| 47 | PAK2 | 0.84895338 |
| 48 | NTRK3 | 0.84221205 |
| 49 | MAP3K3 | 0.84045467 |
| 50 | EEF2K | 0.80814704 |
| 51 | DYRK1B | 0.80754607 |
| 52 | ADRBK1 | 0.79270032 |
| 53 | PRKD1 | 0.77309754 |
| 54 | SIK1 | 0.74552758 |
| 55 | JAK1 | 0.73275579 |
| 56 | MARK2 | 0.72586008 |
| 57 | RPS6KA2 | 0.72471034 |
| 58 | PRKG1 | 0.70933009 |
| 59 | MAP3K7 | 0.70098716 |
| 60 | MAP3K2 | 0.70004143 |
| 61 | PRKAA2 | 0.69882493 |
| 62 | TESK1 | 0.69078557 |
| 63 | PDGFRB | 0.67866074 |
| 64 | FGFR4 | 0.65913187 |
| 65 | TBK1 | 0.65074393 |
| 66 | SGK2 | 0.62588955 |
| 67 | PTK2B | 0.61490988 |
| 68 | CSNK2A2 | 0.61047866 |
| 69 | STK38 | 0.61047452 |
| 70 | ROCK1 | 0.60902171 |
| 71 | MAPK3 | 0.59063568 |
| 72 | PHKG1 | 0.55553614 |
| 73 | PHKG2 | 0.55553614 |
| 74 | ZAP70 | 0.55355624 |
| 75 | MAPK1 | 0.53850601 |
| 76 | MAP4K1 | 0.52446005 |
| 77 | MAP3K1 | 0.52367269 |
| 78 | SGK223 | 0.52265456 |
| 79 | SGK494 | 0.52265456 |
| 80 | RET | 0.51084854 |
| 81 | RPS6KA1 | 0.49656914 |
| 82 | SGK3 | 0.49516753 |
| 83 | RPS6KL1 | 0.47592662 |
| 84 | RPS6KC1 | 0.47592662 |
| 85 | JAK2 | 0.47388665 |
| 86 | STK4 | 0.47056340 |
| 87 | ROCK2 | 0.45958174 |
| 88 | CDK12 | 0.42911053 |
| 89 | ICK | 0.42049406 |
| 90 | MTOR | 0.41671881 |
| 91 | JAK3 | 0.40914764 |
| 92 | PKN2 | 0.40026481 |
| 93 | RPS6KA6 | 0.39044188 |
| 94 | OXSR1 | 0.38800548 |
| 95 | HCK | 0.38657603 |
| 96 | LCK | 0.37775974 |
| 97 | PDK2 | 0.33873312 |
| 98 | LYN | 0.32579169 |
| 99 | PTK2 | 0.32285954 |
| 100 | CAMK1 | 0.32150099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Salivary secretion_Homo sapiens_hsa04970 | 7.03533322 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79562009 |
| 3 | Malaria_Homo sapiens_hsa05144 | 2.52669404 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.23071938 |
| 5 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.16993419 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.94497696 |
| 7 | Renin secretion_Homo sapiens_hsa04924 | 1.62594788 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50488893 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.49782539 |
| 10 | Amoebiasis_Homo sapiens_hsa05146 | 1.42010193 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.38019814 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.33495246 |
| 13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33190360 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31666597 |
| 15 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.26408979 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23975362 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22952479 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.18645438 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17716833 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16437893 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12677415 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.12194666 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11884445 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07679396 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06547145 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.04563965 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02961770 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01761366 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00942193 |
| 30 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99716412 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 0.99477346 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97484042 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97263521 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97240168 |
| 35 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96087598 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 0.95778176 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92246369 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91950833 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90386926 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 0.90109645 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89428171 |
| 42 | Asthma_Homo sapiens_hsa05310 | 0.88146282 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88034493 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.85937400 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81334320 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80706598 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79191281 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 0.78114474 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76120148 |
| 50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75373791 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74002433 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73151774 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69925022 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67487108 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66593843 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.64817252 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63812463 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63707529 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.63437920 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62922585 |
| 61 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61866660 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.61685192 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61099041 |
| 64 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60810939 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60484482 |
| 66 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59714146 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59411609 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.58577186 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.57392010 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.57270873 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55316980 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.54863882 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.54761877 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54353034 |
| 75 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53708496 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53276999 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51951520 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51169574 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49157078 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.49121806 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48388072 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.48094806 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47871631 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46182925 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45593318 |
| 86 | Melanoma_Homo sapiens_hsa05218 | 0.45384726 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45151501 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.44189419 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43993874 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43785893 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43335229 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42120148 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41816736 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41321436 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41131893 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.40370923 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40216070 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.40166681 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.39395599 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39361373 |

